Should we evaluate for cardiovascular disease in patients with cushing's syndrome?

Clinical Endocrinology

Volumn 71, Issue 6, 2009, Pages 768-771

  Fallo, Francesco ^a   Sonino, Nicoletta ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CUSHING SYNDROME; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HEART DISEASE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; METABOLIC DISORDER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; CUSHING SYNDROME; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCORTISONE; RISK FACTORS;

EID: 70449372275     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03610.x     Document Type: Short Survey

References (30)

1. Boscaro, M., Barzon, L., Fallo, F. et al. (2001) Cushing's syndrome. Lancet, 357, 783 791.
2. Arnaldi, G., Angeli, A., Atkinson, A.B. et al. (2003) Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 88, 5593 5602.
3. Walker, B.R. (2007) Glucocorticoids and cardiovascular disease. European Journal of Endocrinology, 157, 545 559.
4. Etxabe, J. Vazquez, J.A. (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology (Oxford), 40, 479 484.
5. Grundy, S.M., Cleeman, J.I., Daniels, S.R. et al. (2005) American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735 2752.
6. Lee, C.M., Huxley, R.R., Wildman, R.P. et al. (2008) Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. Journal of Clinical Epidemiology, 61, 646 653.
7. Mancini, T., Kola, B., Mantero, F. et al. (2004) High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clinical Endocrinology (Oxford), 61, 768 777.
8. Colao, A., Pivonello, R., Spiezia, S. et al. (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism, 84, 2664 2672.
9. Boscaro, M., Sonino, N., Scarda, A. et al. (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 3662 3666.
10. Imai, Y., Abe, K., Sasaki, S. et al. (1988) Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension, 12, 11 19. (Pubitemid 18186327)
11. Sonino, N., Fallo, F., Opocher, G. et al. (1992) Hypertension in Cushing's syndrome. Medical Science Research, 20, 431 434.
12. Withworth, J.A., Mangos, G.J. Kelly, J.J. (2000) Cushing, cortisol, and cardiovascular disease. Hypertension, 36, 912 916.
13. Magiakou, M.A., Smyrnaki, P. Chrousos, G.P. (2006) Hypertension in Cushing's syndrome. Best Practice & Research Clinical Endocrinology & Metabolism, 20, 467 482.
14. Fallo, F., Maffei, P., Dalla Pozza, A. et al. (2009) Cardiovascular autonomic function in Cushing's syndrome. Journal of Endocrinological Investigation, 32, 41 45.
15. Fallo, F., Paoletta, A., Tona, F. et al. (1993) Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's sindrome. Journal of Internal Medicine, 234, 595 598.
16. Fallo, F., Sonino, N., Barzon, L. et al. (1995) Effect of surgical treatment on hypertension in Cushing's syndrome. American Journal of Hypertension, 9, 77 80.
17. Lodish, M.B., Sinaii, N., Patronas, N. et al. (2009) Blood pressure in pediatric patients with Cushing syndrome. Journal of Clinical Endocrinology and Metabolism, 94, 2002 2008.
18. Cushing, H. (1932) The basophil adenomas of the pituitary body and their clinical manifestations. Bulletin of the Johns Hopkins Hospital, 50, 127 195.
19. Fallo, F., Budano, S., Sonino, N. et al. (1994) Left ventricular characteristics in Cushing's syndrome. Journal of Human Hypertension, 8, 509 513.
20. Muiesan, M.L., Lupia, M., Salvetti, M. et al. (2003) Left ventricular and functional characteristics in Cushing's syndrome. Journal of the American College of Cardiology, 41, 2275 2279.
21. Baykan, M., Erem, C., Gedikli, O. et al. (2008) Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's syndrome. Echocardiography, 25, 182 190.
22. Faggiano, A., Pivonello, R., Spiezia, S. et al. (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease remission. Journal of Clinical Endocrinology and Metabolism, 88, 2527 2533.
23. Albiger, N., Testa, R.M., Almoto, B. et al. (2006) Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Hormone and Metabolic Research, 38, 405 410.
24. Baykan, M., Erem, C., Gedikli, O. et al. (2007) Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's syndrome. Endocrine, 31, 300 304. (Pubitemid 47574984)
25. Terzolo, M., Allasino, B., Bosio, S. et al. (2004) Hyperomocystinemia in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 89, 3745 3751.
26. Ermetici, F., Malavazos, A.E., Corbetta, S. et al. (2008) Soluble adhesion molecule levels in patients with Cushing's syndrome before and after cure. Journal of Endocrinological Investigation, 31, 389 392.
27. Kristo, C., Ueland, T., Godano, K. et al. (2008) Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome. Journal of Endocrinological Investigation, 31, 400 405.
28. Tauchmanovà, L., Rossi, R., Biondi, B. et al. (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 87, 4872 4878.
29. Sonino, N., Boscaro, M. Fallo, F. (2005) Pharmacologic treatment of Cushing syndrome. New targets for therapy. Treatments in Endocrinology, 4, 87 96.
30. Mullan, K.R. Atkinson, A.B. (2008) Endocrine clinical update: were are we in the therapeutic management of pituitary-dependent hypercortisolism? Clinical Endocrinology (Oxford), 68, 327 337.